The Tal1 oncoprotein inhibits E47-mediated transcription - Mechanism of inhibition

被引:61
作者
Park, ST [1 ]
Sun, XH [1 ]
机构
[1] NYU, Med Ctr, Dept Cell Biol, New York, NY 10016 USA
关键词
D O I
10.1074/jbc.273.12.7030
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Tall oncogene is a class II basic helix-loop-helix (bHLH) transcription factor, overexpressed in as much as 60% of T cell acute lymphoblastic leukemia cases. Like other class II bHLH proteins, Tall can heterodimerize with the class I bHLH proteins, such as E47, and bind to a DNA recognition sequence termed E box. Therefore, it is believed that the oncogenic capacity of Tall lies in its ability, as a heterodimer with E47, to activate aberrantly a set of "leukemogenic" genes in T cells. However, compared with E47 homodimers, Tal1/E47 heterodimers are very poor transactivators. Thus the effect of Tall is actually to inhibit E47 homodimer activity. Here we propose that the transforming properties of Tall are the result of its ability to inhibit E47 activity. We address the mechanism of Tall inhibition and demonstrate that Tal1/E47 heterodimers cannot activate transcription because their respective activation domains are incompatible. Furthermore, we present data showing that Tall can inhibit E47-mediated activation of the CIP1 gene. Finally, we demonstrate that Tall inhibits E47 activity in leukemic T cells.
引用
收藏
页码:7030 / 7037
页数:8
相关论文
共 55 条
[31]   LOSS OF TAL-1 PROTEIN-ACTIVITY INDUCES PREMATURE APOPTOSIS OF JURKAT LEUKEMIC T-CELLS UPON MEDIUM DEPLETION [J].
LEROYVIARD, K ;
VINIT, MA ;
LECOINTE, N ;
JOUAULT, H ;
HIBNER, U ;
ROMEO, PH ;
MATHIEUMAHUL, D .
EMBO JOURNAL, 1995, 14 (10) :2341-2349
[32]  
Mahajan MA, 1996, ONCOGENE, V12, P2343
[33]  
Massari ME, 1996, MOL CELL BIOL, V16, P121
[34]   LYL-1, A NOVEL GENE ALTERED BY CHROMOSOMAL TRANSLOCATION IN T-CELL LEUKEMIA, CODES FOR A PROTEIN WITH A HELIX-LOOP-HELIX DNA-BINDING MOTIF [J].
MELLENTIN, JD ;
SMITH, SD ;
CLEARY, ML .
CELL, 1989, 58 (01) :77-83
[35]   B-CELL-SPECIFIC AND MYOCYTE-SPECIFIC E2-BOX-BINDING FACTORS CONTAIN E12/E47-LIKE SUBUNITS [J].
MURRE, C ;
VORONOVA, A ;
BALTIMORE, D .
MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (02) :1156-1160
[36]   INTERACTIONS BETWEEN HETEROLOGOUS HELIX-LOOP-HELIX PROTEINS GENERATE COMPLEXES THAT BIND SPECIFICALLY TO A COMMON DNA-SEQUENCE [J].
MURRE, C ;
MCCAW, PS ;
VAESSIN, H ;
CAUDY, M ;
JAN, LY ;
JAN, YN ;
CABRERA, CV ;
BUSKIN, JN ;
HAUSCHKA, SD ;
LASSAR, AB ;
WEINTRAUB, H ;
BALTIMORE, D .
CELL, 1989, 58 (03) :537-544
[37]   TISSUE-SPECIFIC REGULATION OF THE INSULIN GENE BY A NOVEL BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTOR [J].
NAYA, FJ ;
STELLRECHT, CMM ;
TSAI, MJ .
GENES & DEVELOPMENT, 1995, 9 (08) :1009-1019
[38]   Transcriptional activity of TAL1 in T cell acute lymphoblastic leukemia (T-ALL) requires RBTN1 or -2 and induces TALLA1, a highly specific tumor marker of T-ALL [J].
Ono, Y ;
Fukuhara, N ;
Yoshie, O .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (07) :4576-4581
[39]   REGULATION OF G(1) PROGRESSION BY E2A AND ID HELIX-LOOP-HELIX PROTEINS [J].
PEVERALI, FA ;
RAMQVIST, T ;
SAFFRICH, R ;
PEPPERKOK, R ;
BARONE, MV ;
PHILIPSON, L .
EMBO JOURNAL, 1994, 13 (18) :4291-4301
[40]   The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages [J].
Porcher, C ;
Swat, W ;
Rockwell, K ;
Fujiwara, Y ;
Alt, FW ;
Orkin, SH .
CELL, 1996, 86 (01) :47-57